At the 2012 Annual Meeting
June 25-27, 2012
Hyatt Regency Hotel
Title: Google, Medical Apps, and the FDA
The Food and Drug Administration (FDA) announced in 2011 that it would begin overseeing certain medical applications for mobile devices that could present a risk to patients if the apps do not work as intended. In July 2011, FDA published proposed guidelines on how it intends to regulate "mobile medical apps." But does such oversight appear to be necessary and sufficiently targeted, and can it be exercised in a way that does not stifle innovation? Come learn about FDA�s foray into regulating apps and online advertising through search engines and social media, the origins of the FDA initiative, and how companies need to prepare for this new regulatory overlay in the social media and app space. There is an impending culture clash between Washington and Silicon Valley in this space, and even the major players do not know how it may be resolved.
Eric Hargan, Esquire
Greenberg Traurig LLP, Chicago, IL